Woodline Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $801K | Hold |
|
|||||
|
2025
Q2 | $615K | Hold |
|
|||||
|
2025
Q1 | $844K | Hold |
|
|||||
|
2024
Q4 | $1.61M | Sell |
|
|||||
|
2024
Q3 | $3.88M | Sell |
|
|||||
|
2024
Q2 | $6.2M | Buy |
|
|||||
|
2024
Q1 | $22.6M | Buy |
|
|||||
|
2023
Q4 | $21.3M | Buy |
|
|||||
|
2023
Q3 | $20.1M | Sell |
|
|||||
|
2023
Q2 | $30.9M | Sell |
|
|||||
|
2023
Q1 | $37.2M | Buy |
|
|||||
|
2022
Q4 | $2.95M | Sell |
|
|||||
|
2022
Q3 | $6.93M | Buy |
|
|||||
|
2022
Q2 | $5.09M | Buy |
|
|||||
|
2022
Q1 | $1.88M | Sell |
|
|||||
|
2021
Q4 | $30.9M | Sell |
|
|||||
|
2021
Q3 | $33.8M | Buy |
|
|||||
|
2021
Q2 | $26.9M | Buy |
|
|||||
|
2021
Q1 | $6.25M | Buy |
|
|||||
|
2020
Q4 | $7.27M | Buy |
|
|||||
|
2020
Q3 | $4.51M | Buy |
|
|||||
|
2020
Q2 | $2.1M | Buy |
|